经尿道等离子体双极电切术治疗前列腺增生

Transurethral plasmakinetic vaporization of prostate for treatment of benign prostate hyperplasia

目的初步总结经尿道等离子体双极电切术治疗前列腺增生(BPH)的临床体会。方法回顾性分析经尿道等离子体双极电切术治疗BPH56例的临床资料。结果术中出血少,无前列腺电切综合征(TURS)。术后随访1～12个月,术前国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)及剩余尿(PVR)分别为(26.3±3.1)分、(5.3±0.4)分、(8.2±2.3)mL/s及(165±35)mL,术后分别为(8.5±0.6)分、(1.5±0.2)分、(18.5±2.5)mL/s及(10±2)mL,无尿失禁。结论经尿道等离子体双极电切术治疗BPH具有安全性高、并发症少、疗效好、易于掌握推广的优点。

[Objective] To summarize the clinical experienec of transurethral plasmakinetic vaporization of prostate （TUPKVP）. [Methods] 56 patients with symptomatic BHP were treated by TUPKVP. [Results] All patients were followed up of 1-12months postoperatively. The IPSS decreased from （26.3±3.1） to （8.5±0.6）. The QOL decreased from （5.3±0.4） to （1.5±0.2）. The Qmax increased from （8.2±2.3） mL/s to （18.5±2.5） mL/s. The PVR decreased from （165±35） mL to （10±2） mL. [Conclusions] It is suggested that TUPKVP is of efficacy, high safety and less complications.